Skip to content
10-K

Annual Report

BIONIK LABORATORIES CORP.

0001410578-23-001453

← back to feed
Filed
Jun 21, 2023 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Jun 16, 2023 12.48M sh
Shares Diluted FY 2023 · Mar 31, 2023 6.9M sh
Shares Diluted FY 2023 · Mar 31, 2022 5.84M sh
Operating Cash Flow FY 2023 · Mar 31, 2023 −$3.39M
Operating Cash Flow FY 2023 · Mar 31, 2022 −$4.15M
Cash And Equivalents FY 2023 · Mar 31, 2023 $427.38K
Cash And Equivalents FY 2023 · Mar 31, 2022 $1.99M
Stockholders Equity FY 2023 · Mar 31, 2023 −$1.64M
Stockholders Equity FY 2023 · Mar 31, 2022 $2.93M
Stockholders Equity FY 2023 · Mar 31, 2021 $3.28M
Current Liabilities FY 2023 · Mar 31, 2023 $2.31M
Current Liabilities FY 2023 · Mar 31, 2022 $1.49M
Total Liabilities FY 2023 · Mar 31, 2023 $5M
Total Liabilities FY 2023 · Mar 31, 2022 $1.75M
Current Assets FY 2023 · Mar 31, 2023 $2.78M
Current Assets FY 2023 · Mar 31, 2022 $4.58M
Total Assets FY 2023 · Mar 31, 2023 $3.36M
Total Assets FY 2023 · Mar 31, 2022 $4.68M
Eps Diluted FY 2023 · Mar 31, 2023 −$0.72
Eps Diluted FY 2023 · Mar 31, 2022 −$1.78
Eps Basic FY 2023 · Mar 31, 2023 −$0.72
Eps Basic FY 2023 · Mar 31, 2022 −$1.78
Sga Expense FY 2023 · Mar 31, 2023 $2.93M
Sga Expense FY 2023 · Mar 31, 2022 $2.81M
Rd Expense FY 2023 · Mar 31, 2023 $903.22K
Rd Expense FY 2023 · Mar 31, 2022 $998.52K
Net Income FY 2023 · Mar 31, 2023 −$4.95M
Net Income FY 2023 · Mar 31, 2022 −$10.41M
Operating Income FY 2023 · Mar 31, 2023 −$4.83M
Operating Income FY 2023 · Mar 31, 2022 −$9.97M
Gross Profit FY 2023 · Mar 31, 2023 $989.88K
Gross Profit FY 2023 · Mar 31, 2022 $953.26K
Cost Of Revenue FY 2023 · Mar 31, 2023 $815.33K
Cost Of Revenue FY 2023 · Mar 31, 2022 $320.45K
Revenue FY 2023 · Mar 31, 2023 $1.81M
Revenue FY 2023 · Mar 31, 2022 $1.27M
Stock Issued FY 2023 · Feb 28, 2015 1.75K sh